MedTrace Logo

PIMPmyHospital: a Mobile App to Improve Emergency Care Efficiency and Communication

NCT05203146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-11-07

Study results available
· View outcomes & findings →

Summary

This pilot study is a prospective, single-center, randomized, controlled trial in a tertiary pediatric emergency department with two parallel groups of voluntary post-graduate year 1 to 5 pediatric residents and registered pediatric emergency nurses. The impact of an mHealth support tool will be compared to conventional methods on the retrieval of laboratory data from the patient's electronic record, and on team collaboration in a semi-simulated emergency department environment. Ten participants are randomized (1:1). The primary endpoint is the time from the availability of new laboratory results for a given patient to their consideration by participants, measured in minutes using a stopwatch.

Conditions

  • Pediatric Emergency Medicine
  • Communication

Interventions

DEVICE

PIMPmyHospital (mobile health tool)

Each participant will first be asked to retrieve a factious patient's laboratory results on the app when randomly made available, and then reach a colleague (role played by a study investigator) when asked to do so by a text message on the app.

OTHER

Conventional method

Each participant will first be asked to retrieve a factious patient's laboratory results from the emergency department's computerized patient data system when randomly made available, and then contact a colleague (role played by a study investigator) when asked to do so (request made by a second study investigator).

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER

  • Pediatric Clinical Research Platform

    lead OTHER

Principal Investigators

  • Johan N Siebert, MD · Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-06
Primary Completion
2021-09-06
Completion
2021-09-06

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05203146 on ClinicalTrials.gov